These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 25843731

  • 1. Prevention of human papillomavirus-associated cancers.
    Dillner J.
    Semin Oncol; 2015 Apr; 42(2):272-83. PubMed ID: 25843731
    [Abstract] [Full Text] [Related]

  • 2. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
    Smelov V, Elfström KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.
    Int J Cancer; 2015 Mar 01; 136(5):1171-80. PubMed ID: 25043476
    [Abstract] [Full Text] [Related]

  • 3. Are 20 human papillomavirus types causing cervical cancer?
    Arbyn M, Tommasino M, Depuydt C, Dillner J.
    J Pathol; 2014 Dec 01; 234(4):431-5. PubMed ID: 25124771
    [Abstract] [Full Text] [Related]

  • 4. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G.
    Curr Probl Dermatol; 2014 Dec 01; 45():98-122. PubMed ID: 24643181
    [Abstract] [Full Text] [Related]

  • 5. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ.
    Scand J Infect Dis Suppl; 2009 Dec 01; 108():2-32. PubMed ID: 19939209
    [Abstract] [Full Text] [Related]

  • 6. [HPV and cancer].
    Spano JP, Marcelin AG, Carcelin G.
    Bull Cancer; 2005 Jan 01; 92(1):59-64. PubMed ID: 15689325
    [Abstract] [Full Text] [Related]

  • 7. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 01; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 8. HPV-beyond cervical cancer (online resource center).
    Alexander KA, Giuliano AR.
    Am J Med; 2012 Jul 01; 125(7):S1. PubMed ID: 22727241
    [Abstract] [Full Text] [Related]

  • 9. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK.
    J Adolesc Health; 2010 Apr 01; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Apr 20; 61():258-61. PubMed ID: 22513527
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of human papillomavirus types in cervical and oral cancers in central India.
    Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N.
    Vaccine; 2009 Jan 29; 27(5):636-9. PubMed ID: 19056450
    [Abstract] [Full Text] [Related]

  • 12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J, Luckett R, Feldman S.
    Curr Probl Cancer; 2018 Sep 20; 42(5):493-506. PubMed ID: 30041818
    [Abstract] [Full Text] [Related]

  • 15. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC.
    Indian J Med Res; 2009 Sep 20; 130(3):222-33. PubMed ID: 19901431
    [Abstract] [Full Text] [Related]

  • 16. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P.
    Orv Hetil; 2013 Apr 21; 154(16):603-18. PubMed ID: 23587540
    [Abstract] [Full Text] [Related]

  • 17. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 21; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX.
    Expert Opin Pharmacother; 2011 Oct 21; 12(14):2189-204. PubMed ID: 21756205
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J.
    Int J Infect Dis; 2007 Nov 21; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [Abstract] [Full Text] [Related]

  • 20. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 21; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.